Eyal is the Laura and Isaac Perlmutter Chair of Cancer Research for the Faculty of Medicine at Technion Israel Institute of Technology in Haifa, Israel.  He studies the metabolic adaptations that support tumor growth under metabolic stress.  Specifically, he explores vulnerabilities induced by the loss of the metabolic tumor suppressors fumarate hydratase (FH) and succinate dehydrogenase (SDH).

Eyal received his BSc in agriculture from Hebrew University, as well as an MSc and a PhD in molecular cell biology from the Weizmann Institute of Science.  In 1998, he became an EMBO fellow at the University of Chicago and later became a Leukemia and Lymphoma Society Special Fellow at the University of Pennsylvania.  In 2003, he moved to the Cancer Research-UK Beatson Institute in Glasgow and was then appointed as Professor of Molecular Cell Biology at the University of Glasgow in 2009.